Improving Human Life by Advancing the Field of Transplantation
FDA Approves Drug to Prevent Kidney Transplant Rejection
A new type of drug for keeping transplanted kidneys functioning was approved by the FDA yesterday. Nulojix (belatacept), developed by Bristol-Myers Squibb Co., was approved for preventing rejection of a transplanted kidney in adult patients.
Related Content/Other News
Featured Event
What's New
